Moderna eyes three billion COVID vaccine doses in 2022
US pharmaceutical firm Moderna said Thursday it expects to increase global production of its cutting-edge COVID vaccine to up to three billion doses in 2022.
by ·
US pharmaceutical firm Moderna said Thursday it expects to increase global production of its cutting-edge COVID vaccine to up to three billion doses in 2022.
by · Published May 5, 2021
by · Published May 6, 2021
by · Published April 7, 2021